logo
Select company
Select metric
$ 278.6MCurrent Assets
VS
Market
50
Sector
65
Industry
73
History
40
$ 23.95Close
$ 6.43 - $ 27.76 52-Week Range
Ticker Information

Ticker

ZBIO

Company Name

ZENAS BIOPHARMA INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

ZENAS BIOPHARMA INC - Current Assets Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

ZBIO - AssetsC Historical data
DateCurrent Assets
6/30/2025$ 278.6M
3/31/2025$ 317.81M
12/31/2024$ 355.92M
9/30/2024$ 393.78M
6/30/2024$ 188.6M
12/31/2023$ 59.8M
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • ZENAS BIOPHARMA INC's latest trailing twelve months (TTM) AssetsC stands at $ 59.8M.
  • Over the past 5 years, ZENAS BIOPHARMA INC's average AssetsC has been $ 265.75M.
  • The median AssetsC for ZENAS BIOPHARMA INC during this period was $ 298.2M
  • ZENAS BIOPHARMA INC reached its highest AssetsC over the past 5 years at $ 393.78M.
  • The lowest AssetsC recorded by ZENAS BIOPHARMA INC in the same timeframe $ 59.8M

ZENAS BIOPHARMA INC's AssetsC vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

AssetsC Benchmarks
CompanyAssetsC
ABUS : ARBUTUS BIOPHARMA CORP $ 103.12MQURE : UNIQURE NV $ 408.57MNUVB : NUVATION BIO INC $ 623.21MVIR : VIR BIOTECHNOLOGY INC $ 735.71MBCYC : BICYCLE THERAPEUTICS PLC $ 804.26MIMNM : IMMUNOME INC $ 277.43MRLAY : RELAY THERAPEUTICS INC $ 680.39MCAPR : CAPRICOR THERAPEUTICS INC $ 124.13MTSHA : TAYSHA GENE THERAPIES INC $ 316.26MALMS : ALUMIS INC $ 517.56M

Definition of Current Assets

[Balance Sheet] The current (short-term) portion of [Assets] that are usually convertible to cash within a year; reported if the company operates a classified balance sheet that segments current and non-current assets.

ZBIO - Current Assets, Last 5 years

$ 59.8M

Minimum

Dec 31, 2023

$ 393.78M

Maximum

Sep 30, 2024

$ 265.75M

Average

$ 298.2M

Median

AssetsC Benchmark Analysis

The chart above depicts the distribution of AssetsC for companies in the Total Stock Market. The average AssetsC of the companies is $ 325.11M with a standard deviation of $ 406.03M.
The following table provides additional summary stats:
AssetsC in the Market:
filtered constituents2.9K
min$ 0
max$ 1.66B
average$ 325.11M
median$ 147.87M
std$ 406.03M